HK196796A - Use of aromatic diamines for the treatment of angina pectoris, and diamines therefor - Google Patents

Use of aromatic diamines for the treatment of angina pectoris, and diamines therefor Download PDF

Info

Publication number
HK196796A
HK196796A HK196796A HK196796A HK196796A HK 196796 A HK196796 A HK 196796A HK 196796 A HK196796 A HK 196796A HK 196796 A HK196796 A HK 196796A HK 196796 A HK196796 A HK 196796A
Authority
HK
Hong Kong
Prior art keywords
dimethoxyphenyl
ethyl
phenyl
propyl
methylamino
Prior art date
Application number
HK196796A
Other languages
German (de)
English (en)
French (fr)
Inventor
Maschler Harald
Original Assignee
Beecham - Wuelfing Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham - Wuelfing Gmbh & Co. Kg filed Critical Beecham - Wuelfing Gmbh & Co. Kg
Publication of HK196796A publication Critical patent/HK196796A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
HK196796A 1986-02-15 1996-10-24 Use of aromatic diamines for the treatment of angina pectoris, and diamines therefor HK196796A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868603765A GB8603765D0 (en) 1986-02-15 1986-02-15 Compounds

Publications (1)

Publication Number Publication Date
HK196796A true HK196796A (en) 1996-11-01

Family

ID=10593121

Family Applications (1)

Application Number Title Priority Date Filing Date
HK196796A HK196796A (en) 1986-02-15 1996-10-24 Use of aromatic diamines for the treatment of angina pectoris, and diamines therefor

Country Status (11)

Country Link
US (1) US5494933A (da)
EP (1) EP0233762B1 (da)
JP (2) JP2543690B2 (da)
AU (1) AU6877987A (da)
DE (1) DE3781174T2 (da)
DK (1) DK75587A (da)
GB (1) GB8603765D0 (da)
HK (1) HK196796A (da)
NZ (1) NZ219267A (da)
PT (1) PT84294B (da)
ZA (1) ZA871062B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1205124B (it) * 1987-06-05 1989-03-15 Simens Soteta Italiana Medicin Composto attivo nella terapia carciovascolare
JP2699511B2 (ja) * 1988-01-29 1998-01-19 武田薬品工業株式会社 置換アミン類
IT1229214B (it) * 1989-03-31 1991-07-25 Alfa Wassermann S P A Contrada Processo per la sintesi della n metil 3,4 dimetossifeniletilamina
US5281623A (en) * 1990-08-27 1994-01-25 Eli Lilly And Company Method for treating inflammation
WO1992007819A1 (fr) * 1990-10-25 1992-05-14 Yamanouchi Pharmaceutical Co., Ltd. Derive de tri(alcoxy inferieur)benzene
FR2691064B3 (fr) * 1992-05-14 1996-01-12 Beecham Laboratoires Nouveau medicament pour le traitement de l'arythmie.
FR2694557B1 (fr) * 1992-08-05 1994-09-23 Synthelabo Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique.
FR2710059A1 (fr) * 1993-09-13 1995-03-24 Smithkline Beecham Labo Pharma Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
FR2710065B1 (fr) * 1993-09-13 1996-10-04 Smithkline Beecham Labo Pharma Nouveaux composés, leur procédé de préparation et leur utilisation en tant que médicaments.
FR2715652B1 (fr) * 1994-02-03 1996-03-22 Synthelabo Dérivés de N-[3-[(2,3-dihydro-1H-inden-2-yl)alkyl-amino]propyl]-N-phényl-5,6,7,8-tétrahydronaphtalène-2-carboxamide leur préparation et leur application en thérapeutique.
TW281667B (da) * 1994-02-03 1996-07-21 Synthelabo
WO1996027595A1 (en) * 1995-03-08 1996-09-12 Smithkline Beecham Laboratoires Pharmaceutiques Heterocyclycarboxamides and other compounds for the treatment of the cardiac arrhythmias
GB9513756D0 (en) * 1995-07-06 1995-09-06 Smithkline Beecham Plc Novel process & compounds
CL2008002092A1 (es) * 2007-07-20 2009-05-29 Hoffmann La Roche Conjugado que contiene dos o mas peptidos antifusogenicos y un anticuerpo anti-cd-4; metodo de produccion; composicion farmaceutica que lo comprende; polipeptidos antifusogenicos y uso del conjugado para tratar infecciones viricas.

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2670374A (en) * 1952-05-17 1954-02-23 Searle & Co N-dialkylaminoalkyl aminobenzanilides and n-aralkylaminobenzamides and their salts
US2944081A (en) * 1958-03-14 1960-07-05 American Cyanamid Co Diphenyl alkylenediamines and methods of preparing the same
GB862467A (en) * 1958-03-14 1961-03-08 American Cyanamid Co N-substituted anilides and acid addition salts thereof
FR965M (da) * 1960-02-04 1961-11-27
US3049552A (en) * 1960-11-03 1962-08-14 Merck & Co Inc Furfuryl isocyanates
US3049562A (en) * 1961-03-09 1962-08-14 American Cyanamid Co 1-(aralkyl, lower alkylamino lower alkyl), 1-phenyl, 3, 3-dilower alkylureas
GB1004071A (en) * 1961-07-03 1965-09-08 Council Scient Ind Res Substituted ª‰-phenethylamines and a process for the production thereof
DE1170961B (de) * 1962-04-19 1964-05-27 Roehm & Haas Gmbh Verfahren zur Herstellung von N-(N'-Methyl-N'-ª‰-phenaethylamino-tert.-butyl)-propionaniliden
GB1050132A (da) * 1963-03-01
US3196172A (en) * 1963-05-20 1965-07-20 American Cyanamid Co Trifluoromethylphenylalkylenediamines
US3365453A (en) * 1963-10-28 1968-01-23 Sterling Drug Inc 1-phenyl-4-lower-alkyl-2-piperazinones
GB1232787A (da) * 1967-08-08 1971-05-19
US3528990A (en) * 1967-11-14 1970-09-15 Colgate Palmolive Co 1-aminoalkyl derivatives of 2,1-benzisothiazoline
US3789073A (en) * 1970-04-22 1974-01-29 Squibb & Sons Inc Adamantylalkylaminoalkyl benzamides
CH618571A4 (da) * 1970-05-16 1976-09-30
US4322434A (en) * 1979-05-04 1982-03-30 Schering Corporation N-Substituted-4-(polyfluoro-2-hydroxy-2-propyl)anilines and compounds related thereto
DE3263531D1 (en) * 1981-08-05 1985-06-20 Fisons Plc Amine derivatives, processes for their production and pharmaceutical compositions containing them
US4562201A (en) * 1982-07-26 1985-12-31 American Hospital Supply Corporation Aminomethyl benzanilides
DE3242344A1 (de) * 1982-11-16 1984-05-17 Dr. Karl Thomae Gmbh, 7950 Biberach Neue alkylendiaminoderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
US4657929A (en) * 1983-10-25 1987-04-14 Fisons Plc Compounds
DE3428526A1 (de) * 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue aminoalkohole, verfahren zu deren herstellung sowie diese verbindung enthaltende arzneimittel
US4814455A (en) * 1986-04-16 1989-03-21 Bristol-Myers Company Dihydro-3,5-dicarboxylates
JPH0328137A (ja) * 1989-06-23 1991-02-06 Nippon Sheet Glass Co Ltd 平坦な面を有するガラス容器成形方法

Also Published As

Publication number Publication date
JP2663258B2 (ja) 1997-10-15
DE3781174D1 (de) 1992-09-24
DK75587A (da) 1987-08-16
EP0233762A2 (en) 1987-08-26
JP2543690B2 (ja) 1996-10-16
PT84294A (en) 1987-03-01
DK75587D0 (da) 1987-02-13
AU6877987A (en) 1987-08-20
DE3781174T2 (de) 1993-02-11
GB8603765D0 (en) 1986-03-19
US5494933A (en) 1996-02-27
ZA871062B (en) 1988-10-26
JPS62240653A (ja) 1987-10-21
EP0233762B1 (en) 1992-08-19
JPH08268983A (ja) 1996-10-15
PT84294B (pt) 1989-09-14
EP0233762A3 (en) 1989-05-10
NZ219267A (en) 1990-11-27

Similar Documents

Publication Publication Date Title
US5977367A (en) N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands
US5659033A (en) N-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands
EP0233762B1 (en) Use of aromatic diamines for the treatment of angina pectoris, and diamines therefor
US5763609A (en) Certain pyrrolo pyridine-3-carboxamides; a new class of gaba brain receptor ligands
US5688950A (en) Tricyclic aminoalkylcarboxamides; novel dopamine D3 receptor subtype specific ligands
US4645862A (en) Isoprenylamine derivatives
JP3041834B2 (ja) Ｎ―アミノアルキル―２―アントラキノンカルボキサミド；ドーパミンレセプターサブタイプに特異的な新しい配位子
US5212173A (en) Alkylaminoalkylamine and ether compounds, processes and intermediates for their preparation, and medicaments containing them
JPS5931738A (ja) グリセリン誘導体、その製造方法及びその誘導体を含有する薬剤
US5703235A (en) N-Aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands
US5602174A (en) Treatment
JP3091233B2 (ja) 新規ｎ―アミノアルキル―１―ビフェニレンイル―２―カルボキサミド、新しいドーパミンレセプター・サブタイプ特定リガンド
HU225716B1 (en) Novel n,n'-bridged bis-indolyl-maleimides
US6100255A (en) 3-aminoalkylamino-2H-1,4-benzoxazines and 3-aminoalkylamino-2H-1,4-benzothiazines: dopamine receptor subtype specific ligands
EP0174085A2 (en) Bisarylamides of N,N'-di-[1-aminoalkyl-2]-alkylene diamines having a cardiovascular activity
WO1998039301A1 (en) 1-(isoquinolin-1-yl)-4-(1-phenylmethyl)piperazines; dopamine receptor subtype specific ligands
JPH03294277A (ja) ピペリジン誘導体
WO2008157653A1 (en) Deuterium-enriched oseltamivir
WO1995007884A1 (en) Alkanediamine derivatives and their use in the treatment of arrhythmic and ischaemic rhythm disorders
EP0971916A1 (fr) Derives de n-(arginyl)benzenesulfonamide et leur utilisation comme agents antithrombotiques
EP0719263A1 (en) Heterocyclic carboxamide derivatives with antiarrhythmic activity
JPH11322593A (ja) アセトアミド誘導体を有効成分とする抗癌剤及びチュ―ブリン阻害剤、並びに新規アセトアミド誘導体
JPH07118249A (ja) 新規フェノキシアルキルピペラジン誘導体

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)